Theriva Biologics Inc (TOVX)
0.4195
+0.01
(+2.33%)
USD |
NYAM |
Apr 26, 16:00
0.4199
0.00 (0.00%)
After-Hours: 20:00
Theriva Biologics Enterprise Value: -13.02M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| April 26, 2024 | -13.02M |
| April 25, 2024 | -13.19M |
| April 24, 2024 | -13.90M |
| April 23, 2024 | -13.75M |
| April 22, 2024 | -13.17M |
| April 19, 2024 | -13.10M |
| April 18, 2024 | -12.54M |
| April 17, 2024 | -12.76M |
| April 16, 2024 | -12.83M |
| April 15, 2024 | -12.79M |
| April 12, 2024 | -12.51M |
| April 11, 2024 | -12.67M |
| April 10, 2024 | -12.67M |
| April 09, 2024 | -12.70M |
| April 08, 2024 | -12.57M |
| April 05, 2024 | -12.54M |
| April 04, 2024 | -12.84M |
| April 03, 2024 | -12.50M |
| April 02, 2024 | -12.67M |
| April 01, 2024 | -12.61M |
| March 28, 2024 | -12.18M |
| March 27, 2024 | -11.91M |
| March 26, 2024 | -12.36M |
| March 25, 2024 | -11.75M |
| March 22, 2024 | -11.30M |
| Date | Value |
|---|---|
| March 21, 2024 | -11.59M |
| March 20, 2024 | -9.634M |
| March 19, 2024 | -12.66M |
| March 18, 2024 | -12.50M |
| March 15, 2024 | -13.02M |
| March 14, 2024 | -13.13M |
| March 13, 2024 | -12.50M |
| March 12, 2024 | -12.33M |
| March 11, 2024 | -11.94M |
| March 08, 2024 | -12.16M |
| March 07, 2024 | -12.33M |
| March 06, 2024 | -11.99M |
| March 05, 2024 | -11.75M |
| March 04, 2024 | -11.88M |
| March 01, 2024 | -11.73M |
| February 29, 2024 | -12.24M |
| February 28, 2024 | -12.43M |
| February 27, 2024 | -12.33M |
| February 26, 2024 | -11.99M |
| February 23, 2024 | -12.24M |
| February 22, 2024 | -11.80M |
| February 21, 2024 | -11.76M |
| February 20, 2024 | -12.21M |
| February 16, 2024 | -12.16M |
| February 15, 2024 | -12.14M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-41.16M
Minimum
Dec 22 2022
125.39M
Maximum
Mar 12 2021
-6.824M
Average
-12.51M
Median
Jan 05 2024
Enterprise Value Benchmarks
| NovaBay Pharmaceuticals Inc | 2.329M |
| Palatin Technologies Inc | 19.88M |
| iBio Inc | 16.00M |
| Oragenics Inc | 3.037M |
| Nanoviricides Inc | 7.712M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -5.485M |
| Total Expenses (Quarterly) | 6.217M |
| EPS Diluted (Quarterly) | -0.33 |
| Earnings Yield | -276.5% |